Earnings Preview: Atea Pharmaceuticals


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings report on Monday, 2023-05-08. Here's what investors need to know before the announcement.

Analysts estimate that Atea Pharmaceuticals will report an earnings per share (EPS) of $-0.48.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Atea Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.04, which was followed by a 8.19% drop in the share price the next day.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Here's a look at Atea Pharmaceuticals's past performance and the resulting price change:

QuarterQ4 2022Q3 2022Q2 2022Q1 2022
EPS Estimate-0.45-0.44-0.52-0.58
EPS Actual-0.41-0.10-0.38-0.51
Price Change %-8.19%-9.88%-1.28%2.73%

Stock Performance

Shares of Atea Pharmaceuticals were trading at $3.33 as of May 04. Over the last 52-week period, shares are down 37.15%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Atea Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: EarningsBZI-EP